Sayon Roy Selected Research

Lipids

1/2017	Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
11/2015	Beneficial effects of fenofibric acid on overexpression of extracellular matrix components, COX-2, and impairment of endothelial permeability associated with diabetic retinopathy.
1/2013	Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sayon Roy Research Topics

Disease

49	Diabetic Retinopathy (Retinopathy, Diabetic) 05/2022 - 05/2002
6	Hyperglycemia 10/2019 - 02/2007
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 11/2011
3	Macular Edema 11/2015 - 03/2014
2	Leukostasis 11/2020 - 01/2017
2	Ischemia 11/2019 - 01/2017
2	Inflammation (Inflammations) 01/2017 - 11/2015
2	Glaucoma 01/2016 - 02/2007
2	Type 2 Diabetes Mellitus (MODY) 01/2013 - 05/2008
2	Diabetic Angiopathies (Diabetic Angiopathy) 02/2009 - 01/2002
1	Neoplasms (Cancer) 05/2022
1	Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy) 05/2021
1	Optic Atrophy 01/2020
1	Disease Progression 11/2019
1	Bone Diseases (Bone Disease) 10/2019
1	Diabetes Mellitus 10/2019
1	Obesity 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Insulin Resistance 01/2017
1	Schizophrenia (Dementia Praecox) 01/2017
1	Hypertriglyceridemia 01/2017
1	Fibrosis (Cirrhosis) 01/2016
1	Microaneurysm 07/2015
1	Ganglion Cysts (Ganglion) 05/2014
1	Werner Syndrome (Werner's Syndrome) 03/2014
1	Erectile Dysfunction 06/2013
1	Body Weight (Weight, Body) 08/2010
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2008
1	Chest Pain (Chest Pains) 02/2003
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 02/2003
1	Peripheral Arterial Disease 02/2003
1	Immune System Diseases (Immune Disorders) 02/2003
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2002

Drug/Important Bio-Agent (IBA)

35	Retinaldehyde (Retinal)IBA 05/2021 - 05/2002
17	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2002
8	Connexin 43 (Connexin43)IBA 11/2021 - 12/2003
7	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 05/2022 - 12/2018
4	ConnexinsIBA 11/2017 - 12/2003
4	Fibronectins (Fibronectin)IBA 11/2015 - 01/2002
3	Cytochromes c (Cytochrome c)IBA 01/2020 - 07/2010
3	Small Interfering RNA (siRNA)IBA 12/2018 - 07/2005
3	LipidsIBA 01/2017 - 01/2013
2	Hemoglobins (Hemoglobin)IBA 01/2016 - 08/2010
2	Galactose (Galactopyranose)FDA LinkGeneric 07/2015 - 05/2003
2	Proteins (Proteins, Gene)FDA Link 03/2014 - 09/2012
1	Extracellular Matrix ProteinsIBA 01/2020
1	Hormones (Hormone)IBA 10/2019
1	Streptozocin (Streptozotocin)FDA Link 01/2019
1	Olanzapine (Zyprexa)FDA Link 01/2017
1	Antipsychotic Agents (Antipsychotics)IBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	SteroidsIBA 01/2016
1	fenofibric acid FDA Link 11/2015
1	CollagenIBA 11/2015
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2015
1	Pharmaceutical PreparationsIBA 11/2015
1	DAPIIBA 05/2014
1	Fenofibrate (CiL)FDA LinkGeneric 01/2013
1	Blood Glucose (Blood Sugar)IBA 08/2010
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 07/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2008
1	PEGylated soluble tumor necrosis factor receptor IIBA 05/2008
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2003
1	Adenosine DeaminaseIBA 02/2003

Therapy/Procedure

2	Glycemic Control 01/2016 - 02/2009
1	Intravitreal Injections 12/2018
1	Solid-State Lasers 03/2014
1	Lasers (Laser) 03/2014
1	Laser Therapy (Surgery, Laser) 02/2007